LinkedIn co-founder Reid Hoffman warns that Silicon Valley’s software-centric focus is causing investors to overlook the next AI frontier in healthcare and biology.
Silicon Valley’s Software Obsession Limits AI Opportunities
On a recent episode of the a16z podcast, Hoffman argued that the tech industry’s “everything should be done in software” mindset has become a limitation.
“What are the areas where the AI revolution will be magical? That’s probably where I’ve been putting the majority of my co-founding time, invention time,” he said.
AI Could Transform Healthcare And Drug Discovery
Hoffman pointed to biology and healthcare as areas where AI could have transformative effects.
“I’ve been thinking about the intersection of the worlds of atoms and the worlds of bits,” he explained.
Rather than designing drugs independently, he said AI could guide scientists toward the most promising experiments.
“Simply doing prediction and getting that prediction right… It doesn’t have to be right 100% of the time. It has to be right like 1% of the time, because you can validate the other 99%,” Hoffman said.
Wood and Microsoft Highlight AI’s Growing Role In Healthcare
Earlier this month, Microsoft partnered with Harvard Medical School to access health content on diseases and wellness, aiming to diversify its AI sources.
The upcoming Copilot release was set to use Harvard Health Publishing material to deliver medical guidance, as part of Microsoft’s plan to reduce reliance on OpenAI.
Dominic King, Microsoft’s health AI head, said the tool would provide credible and accessible health information.
Last week, Ark Invest CEO Cathie Wood said the real AI revolution was unfolding in hospitals and labs, not in chatbots or self-driving cars, and that Wall Street had largely overlooked it.
She highlighted healthcare as “the most profound application of AI” and noted that AI combined with gene sequencing and CRISPR technology could transform medicine.
Wood also pointed out that technologies like AI, robotics, blockchain, and genomics were entering rapid growth phases, while some big tech firms, including Microsoft, Nvidia, and Alphabet Inc.’s (NASDAQ:GOOG) (NASDAQ:GOOGL), might see slower growth as investors favored “safe” stocks.
Read More:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock